Gupse Adali
@gupseadali.bsky.social
Hepatologist in University of Health Sciences Istanbul Umraniye Tr&Research Hospital @tkadorg @taslorg #TASL GB member #LDLT #HCC #ACLF
Reposted by Gupse Adali
In this interesting study
They evaluated the hazards of ⬆️ distance from LT center on waitlist mortality and receipt of LT
📍No impact on LT waitlist mortality or receipt of LT.
📍Only differences in healthcare utilization in pre-LT
#liversky
journals.lww.com/ajg/abstract...
They evaluated the hazards of ⬆️ distance from LT center on waitlist mortality and receipt of LT
📍No impact on LT waitlist mortality or receipt of LT.
📍Only differences in healthcare utilization in pre-LT
#liversky
journals.lww.com/ajg/abstract...
July 8, 2025 at 6:03 PM
In this interesting study
They evaluated the hazards of ⬆️ distance from LT center on waitlist mortality and receipt of LT
📍No impact on LT waitlist mortality or receipt of LT.
📍Only differences in healthcare utilization in pre-LT
#liversky
journals.lww.com/ajg/abstract...
They evaluated the hazards of ⬆️ distance from LT center on waitlist mortality and receipt of LT
📍No impact on LT waitlist mortality or receipt of LT.
📍Only differences in healthcare utilization in pre-LT
#liversky
journals.lww.com/ajg/abstract...
Reposted by Gupse Adali
🆕CPG❕
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #TIPS in patients with #cirrhosis
Full text here: bit.ly/4hZuMUK
#LiverSky
@easlnews.bsky.social
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #TIPS in patients with #cirrhosis
Full text here: bit.ly/4hZuMUK
#LiverSky
@easlnews.bsky.social
April 3, 2025 at 7:56 AM
🆕CPG❕
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #TIPS in patients with #cirrhosis
Full text here: bit.ly/4hZuMUK
#LiverSky
@easlnews.bsky.social
EASL Clinical Practice Guidelines on TIPS
✅Addresses all aspects of #TIPS in patients with #cirrhosis
Full text here: bit.ly/4hZuMUK
#LiverSky
@easlnews.bsky.social
Reposted by Gupse Adali
EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples
#LiverSky #MedSky
#LiverSky #MedSky
EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples | European Medicines Agency (EMA)
Artificial intelligence tool reliably identifies disease severity and reduces variability
www.ema.europa.eu
March 30, 2025 at 2:13 AM
Reposted by Gupse Adali
🆕CPG❕
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
March 17, 2025 at 8:26 AM
🆕CPG❕
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
EASL-ERN Clinical Practice Guidelines on Wilson’s disease
✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care
Full text here: bit.ly/42aw1vA
#LiverSky
@easlnews.bsky.social
#ERNRARE-LIVER
Reposted by Gupse Adali
🔥off the press:
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
@Annals_Oncology
doi.org/10.1016/j.an...
👉get the lastest update on HCC management
👉Multiple options > MDT is key
@myESMO @EASLedu @ILCAnews #livertwitter
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
@Annals_Oncology
doi.org/10.1016/j.an...
👉get the lastest update on HCC management
👉Multiple options > MDT is key
@myESMO @EASLedu @ILCAnews #livertwitter
February 20, 2025 at 1:53 PM
🔥off the press:
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
@Annals_Oncology
doi.org/10.1016/j.an...
👉get the lastest update on HCC management
👉Multiple options > MDT is key
@myESMO @EASLedu @ILCAnews #livertwitter
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
@Annals_Oncology
doi.org/10.1016/j.an...
👉get the lastest update on HCC management
👉Multiple options > MDT is key
@myESMO @EASLedu @ILCAnews #livertwitter
Reposted by Gupse Adali
New review in #FG from @paulnbrennan.bsky.social and #scottisaacs - a great summary of the role of antidiabetic medications in MASLD #liversky
fg.bmj.com/content/earl...
fg.bmj.com/content/earl...
Role of anti-diabetic medications in the management of MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a significant global health challenge due to its rising prevalence and strong association with metabolic syndrome and type 2 diab...
fg.bmj.com
February 21, 2025 at 3:34 PM
New review in #FG from @paulnbrennan.bsky.social and #scottisaacs - a great summary of the role of antidiabetic medications in MASLD #liversky
fg.bmj.com/content/earl...
fg.bmj.com/content/earl...
Reposted by Gupse Adali
A massive document focussed on the nuances of management of patients with #ACLF.
Glad to be a part of this humongous effort led by Prof. Ashok Choudhary and Prof. Shiv Kumar Sarin.
Kudos to all the collaborators 👏👏
link.springer.com/article/10.1...
Glad to be a part of this humongous effort led by Prof. Ashok Choudhary and Prof. Shiv Kumar Sarin.
Kudos to all the collaborators 👏👏
link.springer.com/article/10.1...
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia - Hepatology International
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus...
link.springer.com
February 18, 2025 at 12:51 PM
Reposted by Gupse Adali
A massive document focussed on the nuances of management of patients with #ACLF.
Glad to be a part of this humongous effort led by Prof. Ashok Choudhary and Prof. Shiv Kumar Sarin.
Kudos to all the collaborators 👏👏
link.springer.com/article/10.1...
Glad to be a part of this humongous effort led by Prof. Ashok Choudhary and Prof. Shiv Kumar Sarin.
Kudos to all the collaborators 👏👏
link.springer.com/article/10.1...
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia - Hepatology International
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus...
link.springer.com
February 18, 2025 at 2:31 AM
A massive document focussed on the nuances of management of patients with #ACLF.
Glad to be a part of this humongous effort led by Prof. Ashok Choudhary and Prof. Shiv Kumar Sarin.
Kudos to all the collaborators 👏👏
link.springer.com/article/10.1...
Glad to be a part of this humongous effort led by Prof. Ashok Choudhary and Prof. Shiv Kumar Sarin.
Kudos to all the collaborators 👏👏
link.springer.com/article/10.1...
Reposted by Gupse Adali
🆕 Treatment of refractory #ascites: TIPS, tunneled peritoneal catheter (PeCa), or ascites pump?
🥇 TIPS: lowest incidence of complications
🦠 PeCa: peritonitis & device explantations 📈
👥 Sarah Schütte et al in Hepatology Communications
🔗 bit.ly/42k8too
#liversky #medsky #cirrhosis
🥇 TIPS: lowest incidence of complications
🦠 PeCa: peritonitis & device explantations 📈
👥 Sarah Schütte et al in Hepatology Communications
🔗 bit.ly/42k8too
#liversky #medsky #cirrhosis
January 21, 2025 at 11:06 AM
🆕 Treatment of refractory #ascites: TIPS, tunneled peritoneal catheter (PeCa), or ascites pump?
🥇 TIPS: lowest incidence of complications
🦠 PeCa: peritonitis & device explantations 📈
👥 Sarah Schütte et al in Hepatology Communications
🔗 bit.ly/42k8too
#liversky #medsky #cirrhosis
🥇 TIPS: lowest incidence of complications
🦠 PeCa: peritonitis & device explantations 📈
👥 Sarah Schütte et al in Hepatology Communications
🔗 bit.ly/42k8too
#liversky #medsky #cirrhosis
Reposted by Gupse Adali
Journal of Hepatology is now on Bluesky 🌤️
📢Check our January issue❗️
🎉Celebrating 40 years of discovery in #liverresearch🎉
🙏Thank you to our authors, editors, reviewers, & readers for supporting us on this incredible journey
Full issue here👉https://bit.ly/42en2Kp
#LiverSky
@easlnews.bsky.social
📢Check our January issue❗️
🎉Celebrating 40 years of discovery in #liverresearch🎉
🙏Thank you to our authors, editors, reviewers, & readers for supporting us on this incredible journey
Full issue here👉https://bit.ly/42en2Kp
#LiverSky
@easlnews.bsky.social
January 17, 2025 at 11:10 AM
Journal of Hepatology is now on Bluesky 🌤️
📢Check our January issue❗️
🎉Celebrating 40 years of discovery in #liverresearch🎉
🙏Thank you to our authors, editors, reviewers, & readers for supporting us on this incredible journey
Full issue here👉https://bit.ly/42en2Kp
#LiverSky
@easlnews.bsky.social
📢Check our January issue❗️
🎉Celebrating 40 years of discovery in #liverresearch🎉
🙏Thank you to our authors, editors, reviewers, & readers for supporting us on this incredible journey
Full issue here👉https://bit.ly/42en2Kp
#LiverSky
@easlnews.bsky.social
Reposted by Gupse Adali
Extremely proud of @drjessicadavis for her strong 💪🏼 work on this new guidance re PVT
#livertwitter #liversky
The graph is well worth 1000 words 😊
#livertwitter #liversky
The graph is well worth 1000 words 😊
🤔 Which patients with #PVT should get AC?
🤔Do you band first?
🤔What is data behind DOAC for PVT?
🚨🚨AGA Clinical Practice Update on PVT Mgmt
www.gastrojournal.org/article/S001...
pragmatic review for busy GI with helpful algorithm 👀⬇️
#liversky #gisky #medsky
December 27, 2024 at 1:44 AM
Extremely proud of @drjessicadavis for her strong 💪🏼 work on this new guidance re PVT
#livertwitter #liversky
The graph is well worth 1000 words 😊
#livertwitter #liversky
The graph is well worth 1000 words 😊
Reposted by Gupse Adali
Updated HCC management guidelines by @easlnews.bsky.social
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
December 17, 2024 at 12:48 PM
Updated HCC management guidelines by @easlnews.bsky.social
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
Must read 👇🏼👇🏼👇🏼
www.journal-of-hepatology.eu/article/S016...
#Liversky
Reposted by Gupse Adali
#GastroEdPick Phase II trial of xalnesiran (siRNA targeting #HBV genome) with or without immunomodulator for chronic #hepatitis B (patients on NA therapy), xalnesiran + immunomodulator led to HBsAg loss at 24wks
@nejm.org www.nejm.org/doi/full/10....
#Liversky #Hepsky #IDsky 🦠
@nejm.org www.nejm.org/doi/full/10....
#Liversky #Hepsky #IDsky 🦠
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B | NEJM
Xalnesiran, a small interfering RNA molecule that targets a conserved region of the
hepatitis B virus (HBV) genome and silences multiple HBV transcripts, may have efficacy,
with or without an immun...
www.nejm.org
December 11, 2024 at 10:11 AM
#GastroEdPick Phase II trial of xalnesiran (siRNA targeting #HBV genome) with or without immunomodulator for chronic #hepatitis B (patients on NA therapy), xalnesiran + immunomodulator led to HBsAg loss at 24wks
@nejm.org www.nejm.org/doi/full/10....
#Liversky #Hepsky #IDsky 🦠
@nejm.org www.nejm.org/doi/full/10....
#Liversky #Hepsky #IDsky 🦠
Reposted by Gupse Adali
The siRNA xalnesiran with or without an immunomodulator in chronic hepatitis B - the Piranga ph 2 study
www.nejm.org/doi/pdf/10.1...
#MedSky #LiverSky #IDSky
www.nejm.org/doi/pdf/10.1...
#MedSky #LiverSky #IDSky
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B | NEJM
Xalnesiran, a small interfering RNA molecule that targets a conserved region of the
hepatitis B virus (HBV) genome and silences multiple HBV transcripts, may have efficacy,
with or without an immun...
www.nejm.org
December 5, 2024 at 7:08 AM
The siRNA xalnesiran with or without an immunomodulator in chronic hepatitis B - the Piranga ph 2 study
www.nejm.org/doi/pdf/10.1...
#MedSky #LiverSky #IDSky
www.nejm.org/doi/pdf/10.1...
#MedSky #LiverSky #IDSky
Reposted by Gupse Adali
Liver Transplantation for Cholangiocarcinoma After Chemotherapy & SIRT: An Intention-To-Treat Study
@Transpl_Int
doi.org/10.3389/ti.2...
👉excellent outcome w/ LTX after sequential downstaging
🧐Intersting food for thoughts > need to identify the right pts
@myESMO @EASLedu @ILCAnews #livertwitter
@Transpl_Int
doi.org/10.3389/ti.2...
👉excellent outcome w/ LTX after sequential downstaging
🧐Intersting food for thoughts > need to identify the right pts
@myESMO @EASLedu @ILCAnews #livertwitter
November 26, 2024 at 9:16 AM
Liver Transplantation for Cholangiocarcinoma After Chemotherapy & SIRT: An Intention-To-Treat Study
@Transpl_Int
doi.org/10.3389/ti.2...
👉excellent outcome w/ LTX after sequential downstaging
🧐Intersting food for thoughts > need to identify the right pts
@myESMO @EASLedu @ILCAnews #livertwitter
@Transpl_Int
doi.org/10.3389/ti.2...
👉excellent outcome w/ LTX after sequential downstaging
🧐Intersting food for thoughts > need to identify the right pts
@myESMO @EASLedu @ILCAnews #livertwitter
Reposted by Gupse Adali
#LiverSky
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
November 26, 2024 at 12:11 PM
#LiverSky
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
Is there a #hepsky feed? Thanks to all who contributed to the @AASLD2024 #TLM2024 #liversky it was a perfect online experience 🥰 Excellent presentations Learned new treatment options for #MetALD #foodaddiction
November 24, 2024 at 12:34 PM
Is there a #hepsky feed? Thanks to all who contributed to the @AASLD2024 #TLM2024 #liversky it was a perfect online experience 🥰 Excellent presentations Learned new treatment options for #MetALD #foodaddiction